EP2404629A1 - Verfahren und Vorrichtung zur Steuerung einer extrakorporalen Blutbehandlung in einem medizinischen Gerät - Google Patents
Verfahren und Vorrichtung zur Steuerung einer extrakorporalen Blutbehandlung in einem medizinischen Gerät Download PDFInfo
- Publication number
- EP2404629A1 EP2404629A1 EP10007040A EP10007040A EP2404629A1 EP 2404629 A1 EP2404629 A1 EP 2404629A1 EP 10007040 A EP10007040 A EP 10007040A EP 10007040 A EP10007040 A EP 10007040A EP 2404629 A1 EP2404629 A1 EP 2404629A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- blood
- extra
- measure
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000011282 treatment Methods 0.000 title claims abstract description 262
- 239000008280 blood Substances 0.000 title claims abstract description 180
- 210000004369 blood Anatomy 0.000 title claims abstract description 180
- 238000000034 method Methods 0.000 title claims description 43
- 239000012530 fluid Substances 0.000 claims abstract description 47
- 230000015654 memory Effects 0.000 claims abstract description 35
- 238000003860 storage Methods 0.000 claims abstract description 32
- 230000001276 controlling effect Effects 0.000 claims abstract description 19
- 230000002596 correlated effect Effects 0.000 claims abstract description 14
- 239000012528 membrane Substances 0.000 claims description 20
- 238000000108 ultra-filtration Methods 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 238000001631 haemodialysis Methods 0.000 claims description 9
- 230000036772 blood pressure Effects 0.000 claims description 7
- 230000035699 permeability Effects 0.000 claims description 7
- 238000002615 hemofiltration Methods 0.000 claims description 6
- 238000002616 plasmapheresis Methods 0.000 claims description 4
- 239000012503 blood component Substances 0.000 claims description 3
- 238000006213 oxygenation reaction Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 2
- 238000000502 dialysis Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 8
- 102000003951 Erythropoietin Human genes 0.000 description 7
- 108090000394 Erythropoietin Proteins 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 229940105423 erythropoietin Drugs 0.000 description 7
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 7
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 229960002897 heparin Drugs 0.000 description 6
- 229920000669 heparin Polymers 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 208000001647 Renal Insufficiency Diseases 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 201000006370 kidney failure Diseases 0.000 description 5
- 230000002572 peristaltic effect Effects 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 238000006073 displacement reaction Methods 0.000 description 4
- 238000005534 hematocrit Methods 0.000 description 4
- 230000037452 priming Effects 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 101100284769 Drosophila melanogaster hemo gene Proteins 0.000 description 2
- 208000000857 Hepatic Insufficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002965 anti-thrombogenic effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000000322 hemodialysis Effects 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001994 activation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 229940000032 cardiovascular system drug Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000012623 in vivo measurement Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
- A61M1/1607—Physical characteristics of the dialysate fluid before use, i.e. upstream of dialyser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1601—Control or regulation
- A61M1/1603—Regulation parameters
- A61M1/1605—Physical characteristics of the dialysate fluid
- A61M1/1609—Physical characteristics of the dialysate fluid after use, i.e. downstream of dialyser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3607—Regulation parameters
- A61M1/3609—Physical characteristics of the blood, e.g. haematocrit, urea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3334—Measuring or controlling the flow rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10007040.8A EP2404629B1 (de) | 2010-07-08 | 2010-07-08 | Vorrichtung zur Steuerung einer extrakorporalen Blutbehandlung in einem medizinischen Gerät |
ES10007040T ES2424796T3 (es) | 2010-07-08 | 2010-07-08 | Aparato para controlar un tratamiento de sangre extracorporal en un dispositivo médico |
US13/175,131 US9162020B2 (en) | 2010-07-08 | 2011-07-01 | Method and apparatus for controlling an extra-corporeal blood treatment in a medical device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10007040.8A EP2404629B1 (de) | 2010-07-08 | 2010-07-08 | Vorrichtung zur Steuerung einer extrakorporalen Blutbehandlung in einem medizinischen Gerät |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2404629A1 true EP2404629A1 (de) | 2012-01-11 |
EP2404629B1 EP2404629B1 (de) | 2013-05-29 |
Family
ID=43414266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10007040.8A Active EP2404629B1 (de) | 2010-07-08 | 2010-07-08 | Vorrichtung zur Steuerung einer extrakorporalen Blutbehandlung in einem medizinischen Gerät |
Country Status (3)
Country | Link |
---|---|
US (1) | US9162020B2 (de) |
EP (1) | EP2404629B1 (de) |
ES (1) | ES2424796T3 (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7736328B2 (en) | 2007-07-05 | 2010-06-15 | Baxter International Inc. | Dialysis system having supply container autoconnection |
US8105487B2 (en) | 2007-09-25 | 2012-01-31 | Fresenius Medical Care Holdings, Inc. | Manifolds for use in conducting dialysis |
US8040493B2 (en) | 2007-10-11 | 2011-10-18 | Fresenius Medical Care Holdings, Inc. | Thermal flow meter |
US9199022B2 (en) | 2008-09-12 | 2015-12-01 | Fresenius Medical Care Holdings, Inc. | Modular reservoir assembly for a hemodialysis and hemofiltration system |
US9358331B2 (en) | 2007-09-13 | 2016-06-07 | Fresenius Medical Care Holdings, Inc. | Portable dialysis machine with improved reservoir heating system |
US8597505B2 (en) | 2007-09-13 | 2013-12-03 | Fresenius Medical Care Holdings, Inc. | Portable dialysis machine |
US8240636B2 (en) | 2009-01-12 | 2012-08-14 | Fresenius Medical Care Holdings, Inc. | Valve system |
US9308307B2 (en) | 2007-09-13 | 2016-04-12 | Fresenius Medical Care Holdings, Inc. | Manifold diaphragms |
US8535522B2 (en) * | 2009-02-12 | 2013-09-17 | Fresenius Medical Care Holdings, Inc. | System and method for detection of disconnection in an extracorporeal blood circuit |
CA2960103C (en) | 2007-11-29 | 2020-03-10 | Fredenius Medical Care Holdings, Inc. | System and method for conducting hemodialysis and hemofiltration |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
MX343532B (es) | 2008-10-07 | 2016-11-09 | Fresenius Medical Care Holdings Inc | Sistema de cebado y metodo para sistemas de dialisis. |
CA2928208A1 (en) * | 2008-10-30 | 2010-06-03 | Fresenius Medical Care Holdings, Inc. | Modular, portable dialysis system |
US8840790B2 (en) | 2011-04-27 | 2014-09-23 | Fenwal, Inc. | Systems and methods of controlling fouling during a filtration procedure |
US9201036B2 (en) | 2012-12-21 | 2015-12-01 | Fresenius Medical Care Holdings, Inc. | Method and system of monitoring electrolyte levels and composition using capacitance or induction |
US9157786B2 (en) | 2012-12-24 | 2015-10-13 | Fresenius Medical Care Holdings, Inc. | Load suspension and weighing system for a dialysis machine reservoir |
EP2982397B1 (de) * | 2013-04-01 | 2018-05-23 | Terumo Kabushiki Kaisha | Zirkulationsvorrichtung und verfahren zur steuerung davon |
US9354640B2 (en) | 2013-11-11 | 2016-05-31 | Fresenius Medical Care Holdings, Inc. | Smart actuator for valve |
US9861422B2 (en) * | 2015-06-17 | 2018-01-09 | Medtronic, Inc. | Catheter breach loop feedback fault detection with active and inactive driver system |
US10406269B2 (en) | 2015-12-29 | 2019-09-10 | Fresenius Medical Care Holdings, Inc. | Electrical sensor for fluids |
US10617809B2 (en) | 2015-12-29 | 2020-04-14 | Fresenius Medical Care Holdings, Inc. | Electrical sensor for fluids |
SE1950039A1 (en) * | 2018-10-10 | 2020-04-11 | Gambro Lundia Ab | Flow rate dependent blood leak detection systems and methods |
IL264001A (en) * | 2018-12-27 | 2019-01-31 | Tel Hashomer Medical Res Infrastructure & Services Ltd | A facility for extracorporeal oxidation using a membrane and simultaneous renal replacement therapy |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1396274A1 (de) * | 2002-09-05 | 2004-03-10 | Gambro Lundia AB | Steuerung und Steuerverfahren für eine Blutbehandlungsvorrichtung |
US20040057037A1 (en) * | 2002-07-18 | 2004-03-25 | Nikkiso Co. Ltd. | Blood treatment device and method for blood treatment |
US20080149551A1 (en) * | 1999-11-29 | 2008-06-26 | Nxstage Medical, Inc. | Blood treatment apparatus |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4821795A (en) | 1987-10-22 | 1989-04-18 | Mccord Heat Transfer Corporation | Undulated heat exchanger fin |
FR2680318B1 (fr) * | 1991-08-14 | 1994-01-21 | Hospal Industrie | Rein artificiel et procede de commande. |
AU1976195A (en) | 1994-03-04 | 1995-09-18 | Medical Dimensions, Inc. | Computer system for managing patient care |
US6671563B1 (en) | 1995-05-15 | 2003-12-30 | Alaris Medical Systems, Inc. | System and method for collecting data and managing patient care |
GB2301685A (en) | 1995-06-03 | 1996-12-11 | Simmon Hill | Patient database for hospital records |
US6852090B2 (en) | 1997-02-14 | 2005-02-08 | Nxstage Medical, Inc. | Fluid processing systems and methods using extracorporeal fluid flow panels oriented within a cartridge |
JPH1134198A (ja) | 1997-07-17 | 1999-02-09 | Japan Steel & Tube Constr Co Ltd | シート状複合材、複合管及び建造物の補強・補修方法 |
DE19814687C1 (de) | 1998-04-01 | 1999-02-18 | Fresenius Medical Care De Gmbh | Dialysegerät mit Vorrichtung zur Herstellung von Dialyselösungen |
WO2001049368A1 (en) | 1999-12-29 | 2001-07-12 | Medtronic, Inc. | System of notification of recalled components for a medical device |
US7379885B1 (en) | 2000-03-10 | 2008-05-27 | David S. Zakim | System and method for obtaining, processing and evaluating patient information for diagnosing disease and selecting treatment |
JP2002163370A (ja) | 2000-11-24 | 2002-06-07 | Terumo Corp | 病院選定システム |
US20030023461A1 (en) | 2001-03-14 | 2003-01-30 | Dan Quintanilla | Internet based therapy management system |
US6648823B2 (en) | 2001-07-31 | 2003-11-18 | Medtronic, Inc. | Method and system of follow-up support for a medical device |
US6671549B2 (en) * | 2001-11-16 | 2003-12-30 | Medtronic, Inc. | Pacemaker utilizing QT dynamics to diagnose heart failure |
US20040039602A1 (en) | 2001-11-16 | 2004-02-26 | Greenberg Robert S. | Clinician's assistant system |
US20030140929A1 (en) | 2002-01-29 | 2003-07-31 | Wilkes Gordon J. | Infusion therapy bar coding system and method |
US6796955B2 (en) * | 2002-02-14 | 2004-09-28 | Chf Solutions, Inc. | Method to control blood and filtrate flowing through an extracorporeal device |
US20050065817A1 (en) | 2002-04-30 | 2005-03-24 | Mihai Dan M. | Separation of validated information and functions in a healthcare system |
EP1361535A1 (de) | 2002-05-08 | 2003-11-12 | Siemens Aktiengesellschaft | Verfahren und System zur Unterstützung der Therapieplanung |
US20040059599A1 (en) | 2002-09-25 | 2004-03-25 | Mcivor Michael E. | Patient management system |
JPWO2004089445A1 (ja) | 2003-04-02 | 2006-07-06 | 株式会社塚田メディカル・リサーチ | 電動式輸液注入システム |
DE10339342B3 (de) | 2003-08-25 | 2005-01-20 | Fresenius Medical Care Deutschland Gmbh | Blutbehandlungsvorrichtung |
JP2005276180A (ja) | 2004-02-26 | 2005-10-06 | Toray Ind Inc | 品質管理システム |
CN1946441B (zh) * | 2004-05-07 | 2011-04-13 | 甘布罗伦迪亚股份公司 | 血液处理设备和用来控制注入的方法 |
US7927313B2 (en) | 2004-05-27 | 2011-04-19 | Baxter International Inc. | Medical device configuration based on recognition of identification information |
US20060059145A1 (en) | 2004-09-02 | 2006-03-16 | Claudia Henschke | System and method for analyzing medical data to determine diagnosis and treatment |
DE102005001051B4 (de) | 2005-01-07 | 2007-10-31 | Fresenius Medical Care Deutschland Gmbh | Vorrichtung und Verfahren zur Erkennung von Komplikationen während einer extrakorporalen Blutbehandlung |
US20060224326A1 (en) | 2005-03-31 | 2006-10-05 | St Ores John W | Integrated data collection and analysis for clinical study |
US8543420B2 (en) | 2007-09-19 | 2013-09-24 | Fresenius Medical Care Holdings, Inc. | Patient-specific content delivery methods and systems |
DE102006032926A1 (de) | 2006-07-15 | 2008-01-17 | Fresenius Medical Care Deutschland Gmbh | Verfahren und Vorrichtung zur Vorgabe von Behandlungsparametern für extrakorporale Dialysebehandlungen |
US8025634B1 (en) | 2006-09-18 | 2011-09-27 | Baxter International Inc. | Method and system for controlled infusion of therapeutic substances |
FR2911417B1 (fr) | 2007-01-17 | 2009-02-27 | Gambro Lundia Ab | Suivi de l'acces vasculaire d'un patient soumis a des seances successives de traitement extracorporel de sang |
FR2915105A1 (fr) | 2007-04-19 | 2008-10-24 | Gambro Lundia Ab | Appareil medical de traitement des fluides et procede pour preparer un appareil medical de traitement des fluides. |
FR2925341A1 (fr) | 2007-12-20 | 2009-06-26 | Gambro Lundia Ab | Appareil pour le traitement extracorporel de sang ou plasma recevant plusieurs articles a usage unique |
EP2163272B1 (de) | 2008-09-15 | 2014-06-25 | B. Braun Avitum AG | Vorrichtung zur frühen Vorhersage des Kt/V-Parameters in Nierenersatzbehandlungen |
US9370324B2 (en) | 2008-11-05 | 2016-06-21 | Fresenius Medical Care Holdings, Inc. | Hemodialysis patient data acquisition, management and analysis system |
US8632485B2 (en) * | 2009-11-05 | 2014-01-21 | Fresenius Medical Care Holdings, Inc. | Patient treatment and monitoring systems and methods |
-
2010
- 2010-07-08 EP EP10007040.8A patent/EP2404629B1/de active Active
- 2010-07-08 ES ES10007040T patent/ES2424796T3/es active Active
-
2011
- 2011-07-01 US US13/175,131 patent/US9162020B2/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080149551A1 (en) * | 1999-11-29 | 2008-06-26 | Nxstage Medical, Inc. | Blood treatment apparatus |
US20040057037A1 (en) * | 2002-07-18 | 2004-03-25 | Nikkiso Co. Ltd. | Blood treatment device and method for blood treatment |
EP1396274A1 (de) * | 2002-09-05 | 2004-03-10 | Gambro Lundia AB | Steuerung und Steuerverfahren für eine Blutbehandlungsvorrichtung |
Also Published As
Publication number | Publication date |
---|---|
ES2424796T3 (es) | 2013-10-08 |
US20120010554A1 (en) | 2012-01-12 |
US9162020B2 (en) | 2015-10-20 |
EP2404629B1 (de) | 2013-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2404629B1 (de) | Vorrichtung zur Steuerung einer extrakorporalen Blutbehandlung in einem medizinischen Gerät | |
EP2142235B1 (de) | Gerät für die extrakorporale blutbehandlung | |
EP0951303B1 (de) | Vorrichtung zur herstellung von einer ersatzlösung | |
US20170319771A1 (en) | Apparatus for extracorporeal blood treatment and a control method therefor | |
CN102186514B (zh) | 用来检查置换液在透析器或过滤器上游或下游的供应的方法和装置 | |
AU2013320645B2 (en) | Device and method for detecting recirculation during an extracorporeal blood treatment | |
AU2004210219B2 (en) | Extracorporeal blood treatment machine. | |
EP2745863A1 (de) | Vorrichtung zur extrakorporalen Blutbehandlung | |
US10940256B2 (en) | Hemodialysis system | |
US9119922B2 (en) | Apparatus and method for identifying a tubing system for an extracorporeal blood treatment device | |
US7314554B2 (en) | Extracorporeal blood treatment machine | |
EP2377570A1 (de) | Verbinder für eine Flüssigkeitstransportleitung einer medizinischen Vorrichtung | |
US20230330314A1 (en) | Method for Identifying the Type of a Medical Filter, and Apparatuses | |
CN110740769A (zh) | 用于体外血液治疗的设备和用于在体外血液治疗期间确定血流动力学参数的方法 | |
CN112839691A (zh) | 体外血液处理设备和用于监测体外血液处理设备中的压力的方法 | |
JP7293761B2 (ja) | 透析装置及び回路セットの判定方法 | |
US11806458B2 (en) | Blood treatment device with automatic reduction of a substitution-solution flow rate | |
US20240139396A1 (en) | Method for Assessing a Measured Pressure Value, and Apparatuses | |
CN116916982A (zh) | 用于血液体外处理的一次性回路,用于血液体外处理的装置和相关联的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME RS |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120116 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 613952 Country of ref document: AT Kind code of ref document: T Effective date: 20130615 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010007202 Country of ref document: DE Effective date: 20130801 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2424796 Country of ref document: ES Kind code of ref document: T3 Effective date: 20131008 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 613952 Country of ref document: AT Kind code of ref document: T Effective date: 20130529 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130830 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130930 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130829 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130929 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: VDEP Effective date: 20130529 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130829 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
26 | Opposition filed |
Opponent name: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH Effective date: 20140227 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R026 Ref document number: 602010007202 Country of ref document: DE Effective date: 20140227 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130708 |
|
PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140731 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20140731 |
|
PLBP | Opposition withdrawn |
Free format text: ORIGINAL CODE: 0009264 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
PLBD | Termination of opposition procedure: decision despatched |
Free format text: ORIGINAL CODE: EPIDOSNOPC1 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130708 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20100708 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
PLBM | Termination of opposition procedure: date of legal effect published |
Free format text: ORIGINAL CODE: 0009276 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: OPPOSITION PROCEDURE CLOSED |
|
27C | Opposition proceedings terminated |
Effective date: 20150731 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130529 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20220506 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20220811 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230612 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230607 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20230605 Year of fee payment: 14 |